Latest News

Teva Launches Honestly HD Website to Provide People Living With Huntington’s Disease (HD) Informatio...

Teva Launches Honestly HD Website to Provide People Living With Huntington’s Disease (HD) Information, In

Studies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-m...

Studies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid

CONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Po...

CONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potenti

Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sul...

Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate)

European Commission grants marketing authorization for Ranivisio▼®* (ranibizumab), a biosimilar to L...

European Commission grants marketing authorization for Ranivisio▼®* (ranibizumab), a biosimilar to Lucent

Teva Reports Second Quarter 2022 Financial Results

Teva Reports Second Quarter 2022 Financial Results

Teva Reaches Agreement With San Francisco to Settle Opioid-Related Claims

Teva Reaches Agreement With San Francisco to Settle Opioid-Related Claims

Teva Announces Appointment of New Global R&D and Chief Medical Officer

Teva Announces Appointment of New Global R&D and Chief Medical Officer

Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 2...

Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 20

Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezu...

Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)

Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute

Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute

New Real-World Data Evaluating AJOVY® (fremanezumab-vfrm) Injection Use in Patients With Migraine Pr...

New Real-World Data Evaluating AJOVY® (fremanezumab-vfrm) Injection Use in Patients With Migraine Present

Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache So...

Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society

Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Part...

Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner t

Teva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related Claims

Teva Reaches Agreement With West Virginia to Settle the State’s Opioid-Related Claims